Enpro INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Judith A. Reinsdorf, a Director at Enpro Inc., acquired 74 units of Phantom Stock under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Thomas M. Botts acquired units of Enpro Inc. common stock under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Enpro Inc. reports that Director William Abbey acquired phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Judith A. Reinsdorf, a Director at Enpro Inc., acquired phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Enpro Inc. director Adele M. Gulfo reported transactions involving phantom stock awards, reflecting dividend equivalents and accruals.
NYSE
Enpro Inc. Director Thomas M. Botts reported transactions related to phantom stock awards and dividend equivalents on June 17, 2026.
NYSE
Enpro Inc. Director John Humphrey reported transactions involving phantom stock units, reflecting dividend equivalents and accruals.
NYSE
Director Felix M. Brueck of Enpro Inc. has reported transactions related to phantom stock awards, reflecting dividend equivalents and accruals.
NYSE
Enpro Inc. Director William Abbey acquired dividend equivalent rights on previously granted phantom stock.
NYSE
Director Ronald C. Keating acquired 99.7407 phantom stock units under the Enpro Inc. Deferred Compensation Plan.
NYSE
Director Thomas M. Botts acquired 57.8496 phantom stock units under the Enpro Inc. Deferred Compensation Plan.
NYSE
Director Judith A. Reinsdorf acquired 111.7096 phantom stock units under the Enpro Inc. Deferred Compensation Plan.
NYSE
Director William Abbey acquired 99.74 phantom stock units under the Enpro Inc. Deferred Compensation Plan.
NYSE
Enpro Inc. Director Judith A. Reinsdorf reported the accrual of dividend equivalent rights on phantom stock holdings.
NYSE
Enpro Director Ronald C. Keating increased his beneficial ownership of phantom stock through dividend equivalent accruals.
NYSE
Enpro Inc. Director John Humphrey increased his beneficial ownership of phantom stock through dividend equivalent rights, totaling 17,849.91 shares.
NYSE
Enpro Inc. Director David L. Hauser increased his beneficial ownership of phantom stock through dividend equivalent rights accruals.
NYSE
Enpro Inc. Director Adele M. Gulfo increased her beneficial ownership of phantom stock through dividend equivalent rights accruals.
NYSE
Enpro Inc. Director Felix M. Brueck increased his beneficial ownership of phantom stock through routine dividend equivalent rights accruals.
NYSE
Enpro Inc. Director William Abbey reported the accrual of dividend equivalent rights on phantom stock, increasing his beneficial ownership.
NYSE
Enpro Inc. Director Thomas M. Botts reported the accrual of additional phantom stock units through dividend equivalent rights, increasing his beneficial ownership.
NYSE
Enpro Inc.'s SVP, Controller, and CAO, Steven R. Bower, exercised stock options and subsequently sold a portion of the acquired common stock.
NYSE
Enpro Inc. Director John Humphrey reported the sale of 1,300 common stock shares at a weighted average price of $268.69, executed under a Rule 10b5-1 plan.
NYSE
Enpro Inc. Director Felix M. Brueck reported the sale of 5,853 shares of common stock on February 23, 2026, for approximately $1.6 million.
NYSE
Enpro Inc.'s President and CEO, Eric A. Vaillancourt, was granted 13,351 stock options with an exercise price of $275.37, vesting over three years.
NYSE
Enpro Inc.'s Senior Vice President and Chief Information Officer, Larisa R. Joiner, was granted 988 stock options with an exercise price of $275.37.
NYSE
Enpro Inc.'s EVP and CFO, Joseph F. Bruderek Jr., was granted 3,147 stock options with an exercise price of $275.37, vesting over three years.
NYSE
Enpro Inc.'s SVP, Controller, and CAO, Steven R. Bower, was granted 766 stock options with an exercise price of $275.37, vesting over three years.
NYSE
Enpro Inc.'s EVP and CHRO, Amy Bianchi, was granted 1,488 stock options with a $275.37 exercise price, vesting over three years.
NYSE
Enpro's EVP, GC, and CAO, Robert S. McLean, reported selling 2,000 shares of common stock while simultaneously being granted 2,133 new stock options.